Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionAMP binding

PRPS2 PFKL PFKP PRPS1

2.02e-0721504GO:0016208
GeneOntologyMolecularFunction6-phosphofructokinase activity

PFKL PFKP

1.84e-053502GO:0003872
GeneOntologyMolecularFunctionribose phosphate diphosphokinase activity

PRPS2 PRPS1

6.12e-055502GO:0004749
GeneOntologyMolecularFunctionfructose-6-phosphate binding

PFKL PFKP

6.12e-055502GO:0070095
GeneOntologyMolecularFunctiondiphosphotransferase activity

PRPS2 PRPS1

9.16e-056502GO:0016778
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

PRPS2 MAP4K3 FER DGKA EEF2K PRKDC PFKL REV3L PFKP PRPS1

9.23e-059385010GO:0016772
GeneOntologyMolecularFunctionkinase activity

PRPS2 MAP4K3 FER DGKA EEF2K PRKDC PFKL PFKP PRPS1

1.03e-04764509GO:0016301
GeneOntologyMolecularFunctionphosphofructokinase activity

PFKL PFKP

1.28e-047502GO:0008443
GeneOntologyMolecularFunctioncarbohydrate binding

PRPS2 CRYBG2 PFKL PFKP PRPS1

1.04e-03310505GO:0030246
GeneOntologyMolecularFunctioncarbohydrate kinase activity

PFKL PFKP

1.25e-0321502GO:0019200
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

MAP4K3 FER DGKA EEF2K PRKDC PFKL PFKP

1.83e-03709507GO:0016773
GeneOntologyMolecularFunctiondicarboxylic acid transmembrane transporter activity

SLC25A18 SLC26A9

2.73e-0331502GO:0005310
GeneOntologyBiologicalProcess5-phosphoribose 1-diphosphate metabolic process

PRPS2 PRPS1

7.91e-056482GO:0046391
GeneOntologyBiologicalProcess5-phosphoribose 1-diphosphate biosynthetic process

PRPS2 PRPS1

7.91e-056482GO:0006015
GeneOntologyBiologicalProcessnicotinamide nucleotide metabolic process

PRPS2 HAAO PFKL PFKP PRPS1

1.04e-04202485GO:0046496
GeneOntologyBiologicalProcesspyridine nucleotide metabolic process

PRPS2 HAAO PFKL PFKP PRPS1

1.04e-04202485GO:0019362
GeneOntologyBiologicalProcesspyridine-containing compound metabolic process

PRPS2 HAAO PFKL PFKP PRPS1

1.25e-04210485GO:0072524
GeneOntologyCellularComponent6-phosphofructokinase complex

PFKL PFKP

1.68e-053502GO:0005945
GeneOntologyCellularComponentribose phosphate diphosphokinase complex

PRPS2 PRPS1

5.58e-055502GO:0002189
GeneOntologyCellularComponenttransferase complex

PRPS2 ZYG11A PRKDC PFKL REV3L PFKP SMC5 USP47 FBXW7 PRPS1

7.86e-059635010GO:1990234
GeneOntologyCellularComponenttransferase complex, transferring phosphorus-containing groups

PRPS2 PRKDC PFKL REV3L PFKP PRPS1

1.42e-04335506GO:0061695
GeneOntologyCellularComponentfascia adherens

NRAP VCL

4.30e-0413502GO:0005916
GeneOntologyCellularComponentintercalated disc

AKAP6 NRAP VCL

5.78e-0468503GO:0014704
GeneOntologyCellularComponentDNA repair complex

PRKDC ASCC3

1.37e-0323502GO:1990391
GeneOntologyCellularComponentcell-cell contact zone

AKAP6 NRAP VCL

1.48e-0394503GO:0044291
DomainPHOSPHOFRUCTOKINASE

PFKL PFKP

2.19e-053512PS00433
Domain6-Pfructokinase_euk

PFKL PFKP

2.19e-053512IPR009161
DomainPRPP_SYNTHASE

PRPS2 PRPS1

2.19e-053512PS00114
DomainPhosphofructokinase_CS

PFKL PFKP

2.19e-053512IPR015912
DomainPFK

PFKL PFKP

2.19e-053512PF00365
DomainPRib_PP_synth_CS

PRPS2 PRPS1

2.19e-053512IPR000842
DomainATP_PFK

PFKL PFKP

2.19e-053512IPR022953
DomainPhosphofructokinase_dom

PFKL PFKP

2.19e-053512IPR000023
DomainRib-P_diPkinase

PRPS2 PRPS1

7.27e-055512IPR005946
DomainPribosyltran_N

PRPS2 PRPS1

7.27e-055512IPR029099
DomainPribosyltran_N

PRPS2 PRPS1

7.27e-055512PF13793
DomainPribosyl_synth

PRPS2 PRPS1

7.27e-055512PF14572
DomainPribosyltran

PRPS2 PRPS1

3.96e-0411512PF00156
DomainPRTase-like

PRPS2 PRPS1

4.74e-0412512IPR029057
DomainPRibTrfase_dom

PRPS2 PRPS1

4.74e-0412512IPR000836
Domain-

PRPS2 PRPS1

4.74e-04125123.40.50.2020
PathwayKEGG_PENTOSE_PHOSPHATE_PATHWAY

PRPS2 PFKL PFKP PRPS1

9.30e-0727404M1386
Pubmed

Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.

DDX50 SEC24B PRKDC PFKL PFKP PRPS1

2.80e-0718251632239614
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

MXRA5 PKHD1 AHR DGKA SLC26A9 PRKDC PFKL REV3L PFKP

1.11e-0673651929676528
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

CRYL1 IPO9 SEC24B AHR FAM83D PRKDC PFKL ASCC3 PFKP VCL GSPT1

1.54e-061247511127684187
Pubmed

[Increased activity of PRPP synthetase].

PRPS2 PRPS1

2.11e-06251218409517
Pubmed

FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.

FAM83D FBXW7

2.11e-06251224344117
Pubmed

L-fucose reduces gut inflammation due to T-regulatory response in Muc2 null mice.

PRKDC MUC2

2.11e-06251236584066
Pubmed

PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness.

PRPS2 PRPS1

2.11e-06251233493137
Pubmed

Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1.

PKHD1 PRKDC

2.11e-06251224984783
Pubmed

Tissue-differential expression of two distinct genes for phosphoribosyl pyrophosphate synthetase and existence of the testis-specific transcript.

PRPS2 PRPS1

2.11e-0625122537655
Pubmed

FAM83D promotes the progression of 4NQO-induced esophageal carcinoma via inhibiting FBWX7.

FAM83D FBXW7

2.11e-06251239260674
Pubmed

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

DRD2 ANKS1B SLC26A9

4.49e-062251321107309
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

PRPS2 FAM184B SLC25A18 DDX50 PKHD1 ANKS1B DGKA PRKDC PFKP GSPT1 PRPS1

6.19e-061442511135575683
Pubmed

Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches.

PFKL PFKP

6.32e-06351233141153
Pubmed

Expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells with ERN1 knockdown: effect of hypoxia and endoplasmic reticulum stress.

PRPS2 PRPS1

6.32e-06351225816608
Pubmed

Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues.

PFKL PFKP

6.32e-063512156693
Pubmed

Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 encoding phosphoribosylpyrophosphate synthetase subunit I and II isoforms.

PRPS2 PRPS1

6.32e-0635121314091
Pubmed

Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.

PFKL PFKP

6.32e-0635127825568
Pubmed

Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system.

PFKL PFKP

6.32e-0635126451249
Pubmed

Partial reconstitution of mammalian phosphoribosylpyrophosphate synthetase in Escherichia coli cells. Coexpression of catalytic subunits with the 39-kDa associated protein leads to formation of soluble multimeric complexes of various compositions.

PRPS2 PRPS1

6.32e-0635129366267
Pubmed

Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

PFKL PFKP

6.32e-0635126444721
Pubmed

Genomic organization, 5'flanking region and tissue-specific expression of mouse phosphofructokinase C gene.

PFKL PFKP

6.32e-06351211137296
Pubmed

FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.

FAM83D FBXW7

6.32e-06351228407575
Pubmed

Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.

PFKL PFKP

6.32e-0635122960695
Pubmed

Molecular mechanism of c-Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma.

PRPS2 PRPS1

6.32e-06351232391636
Pubmed

Cloning of cDNAs for human phosphoribosylpyrophosphate synthetases 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes.

PRPS2 PRPS1

6.32e-0635121962753
Pubmed

Phosphofructokinase isozyme expression during myoblast differentiation.

PFKL PFKP

6.32e-0635122521854
Pubmed

Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase.

PRPS2 PRPS1

6.32e-06351226175007
Pubmed

Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.

GSDME IPO9 PRKDC PFKL PFKP

7.37e-0618351523956138
Pubmed

Molecular interactions of N-RAP, a nebulin-related protein of striated muscle myotendon junctions and intercalated disks.

NRAP VCL

1.26e-05451210320340
Pubmed

Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.

PRKDC FBXW7

1.26e-05451220823234
Pubmed

BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.

GSDME IPO9 ASCC3 VCL GSPT1

1.64e-0521651531519766
Pubmed

Linkage of phosphoribosylpyrophosphate synthetases 1 and 2, Prps1 and Prps2, on the mouse X chromosome.

PRPS2 PRPS1

2.10e-0555127849396
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

IPO9 DDX50 MAP4K3 SEC24B PRKDC PFKL ASCC3 PFKP VCL GSPT1

2.29e-051353511029467282
Pubmed

Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development.

PRPS2 PFKL PFKP PRPS1

2.43e-0511451428245920
Pubmed

GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease.

MAP4K3 AHR

3.15e-05651230214937
Pubmed

Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.

PRPS2 PRPS1

3.15e-05651224855946
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

PRPS2 IPO9 PRKDC PFKL ASCC3 PFKP VCL GSPT1 PRPS1

3.96e-05114951935446349
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

PRPS2 IPO9 EEF2K PRKDC PFKL PFKP VCL USP47 GSPT1 PRPS1

4.24e-051455511022863883
Pubmed

Ultrastructural and biochemical localization of N-RAP at the interface between myofibrils and intercalated disks in the mouse heart.

NRAP VCL

7.54e-05951211732910
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

FER FAM83D PFKL ASCC3 SMC5 VCL GSPT1

8.60e-0572451736232890
Pubmed

TGFβ pathway is required for viable gestation of Fanconi anemia embryos.

PRKDC VCL

9.42e-051051236441774
Pubmed

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

PRKDC PFKP FBXW7

1.11e-046351337052853
Pubmed

Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex.

PRKDC PFKL PFKP

1.16e-046451322865885
Pubmed

LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.

MAP4K3 PRKDC PFKL PFKP VCL

1.17e-0432751531409639
Pubmed

Defining human ERAD networks through an integrative mapping strategy.

IPO9 PRKDC PFKL PFKP

1.23e-0417351422119785
Pubmed

IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis.

AHR PRKDC

1.90e-041451223853597
Pubmed

Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.

PRKDC USP47 PRPS1

1.94e-047651327542412
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

IPO9 DDX50 DHCR24 PRKDC PFKL ASCC3 PFKP GSPT1 PRPS1

2.20e-04144051930833792
Pubmed

Functional proteomics mapping of a human signaling pathway.

PLEKHB2 KIF18A CPXM2 PFKL ASCC3 VCL

2.21e-0459151615231748
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

IPO9 PRKDC PFKL ASCC3 PFKP FBXW7

2.42e-0460151633658012
Pubmed

SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.

USP47 FBXW7

2.50e-041651229891922
Pubmed

SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.

SEC24B PFKL PFKP VCL GSPT1 PRPS1

2.55e-0460751639147351
Pubmed

Defining the membrane proteome of NK cells.

IPO9 DDX50 DHCR24 DGKA PRKDC PFKL ASCC3 PFKP

2.79e-04116851819946888
Pubmed

Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.

IPO9 PRKDC REV3L

2.89e-048751317148452
Pubmed

Rewiring of embryonic glucose metabolism via suppression of PFK-1 and aldolase during mouse chorioallantoic branching.

PFKL PFKP

3.18e-041851228049690
Pubmed

Requirement for the Mitochondrial Pyruvate Carrier in Mammalian Development Revealed by a Hypomorphic Allelic Series.

PRPS2 PFKL PRPS1

3.51e-049351327215380
Pubmed

The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.

VCL FBXW7

3.55e-041951222405651
Pubmed

Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury.

PFKL VCL

3.94e-042051221270129
Pubmed

The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.

PRKDC ASCC3 PFKP SMC5

4.09e-0423751429564676
Pubmed

A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.

KIF18A PFKL PFKP GKN1 PRPS1

4.20e-0443151533660365
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

PLEKHB2 IPO9 DHCR24 SEC24B PRKDC ASCC3 PFKP

4.29e-0494251731073040
Pubmed

Network organization of the human autophagy system.

SEC24B PRKDC PFKL PFKP GSPT1

4.47e-0443751520562859
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

PRPS2 SLC25A18 DDX50 PRKDC PFKL PFKP PRPS1

4.48e-0494951736574265
Pubmed

C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.

PRPS2 DHCR24 PRKDC PFKL ASCC3 PFKP GSPT1 PRPS1

4.55e-04125751837317656
Pubmed

The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.

DDX50 DHCR24 PRKDC PRPS1

5.22e-0425351429911972
Pubmed

IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice.

AHR PRKDC

5.23e-042351234473953
Pubmed

GGPP depletion initiates metaflammation through disequilibrating CYB5R3-dependent eicosanoid metabolism.

GSDME PFKP

6.19e-042551232913122
Pubmed

Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins.

DRD2 PKHD1

6.19e-042551228154160
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

PRPS2 IPO9 DDX50 PRKDC PFKL ASCC3 GSPT1 PRPS1

6.22e-04131851830463901
Pubmed

DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.

VCL FBXW7 PRPS1

7.04e-0411851337105989
Pubmed

Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease.

PRKDC VCL

7.23e-042751236266428
Pubmed

AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair.

MXRA5 PKHD1 PRKDC

7.57e-0412151331900314
Pubmed

A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.

PRPS2 DHCR24 FAM83D ASCC3 PRPS1

8.43e-0450351536217030
Pubmed

UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.

PRKDC PFKL

8.93e-043051232867711
Pubmed

NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.

PRKDC ASCC3 FBXW7

9.12e-0412951323022380
Pubmed

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

PRKDC PFKL PFKP VCL

9.62e-0429851430737378
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

AKAP6 FAM184B DDX50 MAP4K3 DGKA PFKL KDM1B

9.81e-04108451711544199
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

PRPS2 DNAJC19 DHCR24 PRKDC PFKL PFKP GSPT1 PRPS1

9.87e-04141551828515276
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

IPO9 DDX50 DHCR24 PRKDC PFKL VCL GSPT1 PRPS1

1.03e-03142551830948266
Pubmed

Proximity labeling reveals dynamic changes in the SQSTM1 protein network.

SEC24B FER ASCC3 GSPT1

1.28e-0332251439098523
Pubmed

The genetic architecture of economic and political preferences.

AKAP6 ASCC3

1.36e-033751222566634
Pubmed

USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.

PRPS2 IPO9 PRKDC PFKL PFKP

1.41e-0356551533567341
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

DDX50 DHCR24 SEC24B FAM83D PFKL KDM1B ASCC3 PFKP

1.41e-03149751831527615
Pubmed

Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples.

DRD2 AHR

1.43e-033851214634838
InteractionKDF1 interactions

DDX50 SEC24B PRKDC PFKL PFKP PRPS1

8.72e-06192516int:KDF1
Cytoband7p15

GSDME AHR

1.09e-04145127p15
Cytoband1p32.3

ZYG11A DHCR24

2.12e-03615121p32.3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP4K3 FER PKHD1 PFKP VCL

2.83e-0619451546070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP4K3 FER PKHD1 PFKP VCL

2.83e-06194515abacb6a8d7a9003f2f6c2be0305507f1c1c50347
DrugAC1L1AO2

PRPS2 PFKL PFKP PRPS1

6.68e-0818514CID000001073
Drug2,5-anhydro-D-mannitol

PRPS2 PFKL PFKP PRPS1

6.72e-0731514CID000001494
Drugallulose 6-phosphate

PRPS2 MAP4K3 PKHD1 PFKL PFKP PRPS1

1.63e-06162516CID000000603
Drugisochroman

DRD2 AHR FBXW7

3.79e-0614513CID000096266
DrugQuinolinic Acid

DRD2 AHR HAAO

8.44e-0618513ctd:D017378
DrugUridine diphosphate 2-deoxyglucose

PFKL PFKP

2.94e-054512CID000165519
Druganthranilic acid

PRPS2 AHR HAAO PRPS1

4.74e-0589514CID000000227
DrugAC1L9828

PRPS2 PRPS1

4.90e-055512CID000439794
Drugdeclopramide

DRD2 PRKDC

4.90e-055512CID000070177
Drug6-o-phosphonohexose

PRPS2 PFKL PFKP FBXW7 PRPS1

5.82e-05185515CID000099058
Drugacetyl phosphate

MAP4K3 OXCT2 PFKL PFKP

6.91e-0598514CID000000186
DrugAPP-MP

PRPS2 PRPS1

7.34e-056512CID003081102
Drugpyrimidine-5-nucleotide

PRPS2 PRPS1

7.34e-056512CID000440040
DrugAC1MIX9B

PFKL PFKP

7.34e-056512CID003081623
Drugmethyl iodoacetate

PRPS2 PRPS1

7.34e-056512CID006429536
Drugbenzo(f)quinoline

DRD2 AHR

7.34e-056512ctd:C039108
DrugEsculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A

CRYBG2 GSDME HAAO CASP10 GSPT1

7.84e-051975155411_UP
DrugHexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; PC3; HT_HG-U133A

DRD2 ANXA10 HAAO CASP10 VCL

7.84e-051975155768_UP
Drugglipentide

PFKL PFKP

1.03e-047512CID000065779
Drugdactylarin

PFKL PFKP

1.03e-047512CID000161389
Diseaseglycogen storage disease (implicated_via_orthology)

PFKL PFKP

1.68e-054502DOID:2747 (implicated_via_orthology)
DiseaseTobacco Dependence

DRD2 AHR

2.53e-0414502C0040332
DiseaseNicotine Dependence

DRD2 AHR

2.53e-0414502C0028043
DiseaseNicotine Use Disorder

DRD2 AHR

2.53e-0414502C0376384
Diseasesmoking behavior

NRAP CPXM2 PKHD1 REV3L ASCC3

2.77e-04341505EFO_0004318
Diseaseobsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa

AKAP6 DRD2 GSDME ANKS1B

3.70e-04200504EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
DiseaseTachyarrhythmia

DRD2 AHR

4.23e-0418502C0080203
DiseaseTachycardia

DRD2 AHR

4.23e-0418502C0039231
Diseasedisease of metabolism (implicated_via_orthology)

PFKL PFKP

5.79e-0421502DOID:0014667 (implicated_via_orthology)
DiseaseAdenocarcinoma of large intestine

EEF2K PRKDC FBXW7

5.85e-0496503C1319315
DiseaseWeight Gain

DRD2 AHR PRPS1

6.99e-04102503C0043094
Diseasealcohol use disorder measurement, alcohol dependence

DRD2 PKHD1

7.58e-0424502EFO_0009458, MONDO_0007079
DiseaseSquamous cell carcinoma of lung

MAP4K3 PRKDC

1.35e-0332502C0149782
Diseaseattention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement

AKAP6 NRAP CPXM2 PRKDC REV3L ASCC3

2.26e-03801506EFO_0003888, EFO_0007052, MONDO_0002491
Diseaseunipolar depression, bipolar disorder

DRD2 GSDME ASCC3

2.37e-03156503EFO_0003761, MONDO_0004985
Diseaseschizophrenia (is_marker_for)

DRD2 HAAO

2.54e-0344502DOID:5419 (is_marker_for)
Diseasebipolar disorder

AKAP6 KIF18A DRD2 GSDME ANKS1B

2.88e-03577505MONDO_0004985
Diseasesmoking status measurement

DRD2 NRAP CPXM2 PKHD1 ANKS1B REV3L ASCC3

3.25e-031160507EFO_0006527

Protein segments in the cluster

PeptideGeneStartEntry
VVEPQQQLCQKMKHM

AHR

631

P35869
IINPHEKVQMKSICA

ERI2

286

A8K979
QKTGEHKTMLQMILC

ANXA10

186

Q9UJ72
PVCNKLMHQEQLKVM

HAAO

21

P46952
KITTMQKCVISEHMQ

GSDME

161

O60443
QLMKVVNEMCPNITR

CPXM2

326

Q8N436
VVKMIISAHPNLMSC

ANKS1B

176

Q7Z6G8
AVVQQEIIMMKDCKH

MAP4K3

56

Q8IVH8
EIIMMKDCKHPNIVA

MAP4K3

61

Q8IVH8
VNFMLHKCQMKKPIT

MAGEB16

121

A2A368
PMDMVNIRHAKKAQT

NRAP

631

Q86VF7
MEHKRNICKINPSMV

KIF18A

871

Q8NI77
DPQMHVKMCKKIAQL

FAM184B

31

Q9ULE4
QTCSKVMMHIRNHPV

ECHDC3

126

Q96DC8
QEVLIKTVHMMPMQV

MUC2

4546

Q02817
LPLMECVQMTKEVQK

PFKL

346

P17858
PLMECVQMTQDVQKA

PFKP

356

Q01813
CMDLKVHPEQEKLMT

FAM83D

206

Q9H4H8
PCTIKITHKNQMPML

DGKA

706

P23743
ICKGQQLVMMPNKHN

GSPT1

326

P15170
CIVHKMNKEVMPSIQ

GKN1

81

Q9NS71
PVALMCEQLGISMHK

KDM1B

446

Q8NB78
APQHCPEDISKIMMK

FER

781

P16591
QVVVTCPMEMLKIQL

SLC25A18

116

Q9H1K4
HHVVQDMLVPMKCLQ

DHCR24

381

Q15392
TQVSCSPLEMMKKHV

CRYBG2

866

Q8N1P7
LIDSCEPTQVKHMMQ

FBXW7

256

Q969H0
CETKKNVTEMAMNPH

DDX50

396

Q9BQ39
VKNFPKHMVSSMQQI

IPO9

276

Q96P70
EMEMVLQKQKCNPAH

CASP10

331

Q92851
MKKIGQCPMRVQKEV

CRYL1

176

Q9Y2S2
HKPPKQVDIMQMCII

EEF2K

201

O00418
HPEDMKLCTVIMKSN

DRD2

246

P14416
AMCQIKSQPLVHLMK

SEC24B

1101

O95487
KVHMPMDCINIRTGQ

PLEKHB2

46

Q96CS7
CKMPKKYHMQIVGEI

SLC26A9

301

Q7LBE3
RMKVMLGKVNQCPHQ

PKHD1

3931

P08F94
VTMQHCTKDNTPKIM

OXCT2

436

Q9BYC2
PMIMKQSQSEKAHVE

AKAP6

1481

Q13023
KVKQCVHQIPSVMME

ASCC3

1171

Q8N3C0
EKMQSVQKMFKCHPD

PLEKHS1

81

Q5SXH7
VQKMFKCHPDEVMSI

PLEKHS1

86

Q5SXH7
MLQCTPANMVEVHKD

REV3L

346

O60673
PQEDKMKHCTKIQVI

PRPS2

276

P11908
NIKRNEMVTKHPVMC

ZNF679

76

Q8IYX0
KCKVAMANIQPQMLV

VCL

736

P18206
LFCLHPTKQVMMENK

USP47

611

Q96K76
VMAHLPDVCVNLMKA

PRKDC

1391

P78527
PQEDKMKHCSKIQVI

PRPS1

276

P60891
VCEPIMLTINMKDNK

SMC5

481

Q8IY18
MKHMEPQVKQVFQSL

DNAJC19

26

Q96DA6
CKHENPKMQTMAVSV

ZYG11A

476

Q6WRX3
HGNMVNLVCDIKKPM

MXRA5

326

Q9NR99